To present complex biotech data to senior executives, lead with the bottom line, speak to business impact, and structure your message around what decision makers actually need to approve your proposal. Scientists who master this shift win faster approvals, stronger executive relationships, and more resources for their work.
This article breaks down how biotech professionals can communicate high-level science in a way that resonates with executive decision makers. Key topics include:
In the biotechnology sector, progress is measured in data. A spreadsheet showing positive results from a Phase II trial or a chart detailing enhanced bioavailability can represent years of dedicated research. But the data alone rarely moves decision makers.
The disconnect isn't about intelligence or interest. It's about mindset. Executives are focused on business outcomes, risk, and strategic alignment to company goals. They're not in the room to be educated on methodology; they're in the room to make a decision. As Markus Zirn, SVP of Strategy and Business Development at Workato, puts it: "You have to throw out everything you learned from traditional presentation training. It's not about making a speech that inspires, persuades, or leads. It's about raw decision-making."
When biotech presenters walk in loaded with data and walk out without a decision, the science isn't the problem. The communication is.
Effective executive communication isn't about watering down your science. It's about framing it in a way that maps to how executives think, decide, and act.
Most scientists are trained to build toward a conclusion, walking the audience through methodology before arriving at findings. Executives need the opposite. Start with where you want to end up.
Don't say, "We've been studying the pharmacokinetic profile of this compound and have some promising early results." Say, "We're requesting $750,000 to move this compound into Phase III, based on a projected $2M return and a clear path to FDA submission within 18 months." That's the framing executives can act on.
State your ask and your outcome up front. Then support it with only the clear, brief data that matters to the decision—not everything you know.
Data and your ask need structure. Without it, important findings get lost. The Executive Framework taught in Speaking Up: Presenting to Decision Makers® gives presenters a clear way to organize their content around what executives care about most.
The structure works like this: open with your bottom line (the decision you want from them), then provide the minimum critical data needed to justify it. Organize supporting points around business impact—revenue, risk mitigation, competitive position, or patient outcomes. Anticipate the questions you're likely to face and address them proactively before they derail the conversation.
For biotech leaders, this might mean translating a positive trial result into what it means for the pipeline timeline, what regulatory risk it removes, and what commercial opportunity it creates. Instead of explaining the mechanism of pharmacokinetics in full, describe it as "the journey a drug takes through the body," and connect it directly to why it improves patient adherence and reduces dosing cost. Keep technical detail available for questions—but don't lead with it.
The 10/30 Rule is a practical guide here: in a 30-minute slot, plan for 10 minutes of structured content and leave the remaining 20 for dialogue. Executives expect and value that space.
How you show up matters as much as what you present. Executive presence is the combination of confidence, credibility, and authenticity that signals to decision makers that you are someone whose recommendations can be trusted.
For scientists presenting technical data, this often means shifting from "presenter" mode — where you are delivering information—to "facilitator" mode, where you are guiding a conversation toward a decision. That shift changes everything: your pacing, your eye contact, how you handle interruptions, and how you respond when an executive challenges your assumptions.
Relatable analogies are a tool for presence, not just clarity. Describing an mRNA vaccine's function as delivering a "recipe" to a cell doesn't just make the science accessible, it signals that you understand your audience. Clean, purposeful visuals reinforce the same message: you have done the work of translating your findings into something decision makers can use.
Executive meetings rarely go as planned. A board member may push back on your timeline. Two executives may disagree with each other in the middle of your presentation. You may be told, with no warning, that you now have 10 minutes instead of 30.
These moments don't have to derail you. The PREP model (Position, Reason, Evidence, Position) gives presenters a reliable structure for responding to challenging questions under pressure. Active listening, paraphrasing, and reframing questions are equally important skills. They let you acknowledge objections, redirect the conversation, and keep things moving toward a decision.
Anticipating the questions your audience will ask. What are the financial implications, what does the regulatory pathway look like, what happens if the next trial misses—is part of preparation, not an afterthought. Proactive answers build credibility. Stumbling through reactive ones erodes it.
These strategies can be learned and practiced. Speaking Up: Presenting to Decision Makers® was built specifically for professionals who need to influence senior decision makers. It's grounded in research from interviews with over 50 C-level leaders from Fortune 1000 companies, including Genentech and Abbott Laboratories.
The program gives participants the tools to walk into an executive presentation prepared, confident, focused on the outcome, and ready for executive dialogue. Key components include:
Before you walk into the room, use this four-step process to prepare:
In biotech, the quality of your research matters. But funding, approvals, and momentum all depend on your ability to communicate its value to people who think in outcomes, not data sets. When you lead with the bottom line, structure your message around what decision makers need, and show up with the presence and preparation to handle a dynamic executive conversation, your proposals move faster, and your credibility grows with every presentation.
That's what Speaking Up: Presenting to Decision Makers® teaches, and they are skills worth developing before your next high-stakes meeting.
Executives are focused on outcomes, risk, and strategic alignment, not methodology. When a presentation leads with technical detail rather than a clear outcome and business impact, decision makers can't easily evaluate what action to take. The gap isn't about the quality of the science; it's about how the message is framed for the audience in the room.
What is the Executive Framework, and how does it apply to biotech presentations?The Executive Framework is a structured approach to organizing presentations to senior decision makers. It starts with the bottom line—your ask and the business outcome—then provides only the critical supporting data needed to justify that ask. For biotech leaders, this means connecting trial results or technical findings directly to pipeline timelines, regulatory risk, commercial potential, or patient impact, rather than walking through the full scientific story.
How do you handle tough questions or pushback from executives during a biotech presentation?Preparation is the foundation. Anticipating the hardest questions — about financials, timelines, regulatory risk, or competitive alternatives — and preparing clear, concise responses keeps you in control when the conversation gets challenging. The PREP model (Position, Reason, Evidence, Position) provides a reliable structure for responding under pressure, and skills like active listening and question-reframing help you redirect the dialogue without losing credibility.